» Articles » PMID: 29410278

Use of BMI As the Marker of Adiposity in a Metabolic Syndrome Severity Score: Derivation and Validation in Predicting Long-term Disease Outcomes

Overview
Journal Metabolism
Specialty Endocrinology
Date 2018 Feb 8
PMID 29410278
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Estimates of adiposity in evaluating the metabolic syndrome (MetS) have traditionally utilized measures of waist circumference (WC), whereas body mass index (BMI) is more commonly used clinically. Our objective was to determine if a MetS severity Z-score employing BMI as its measure of adiposity (MetS-Z-BMI) would perform similarly to a WC-based score (MetS-Z-WC) in predicting future disease.

Methods: To formulate the MetS-Z-BMI, we performed confirmatory factor analysis on a sex- and race/ethnicity-specific basis on MetS-related data for 6870 adult participants of the National Health and Nutrition Survey 1999-2010. We then validated this score and compared it to MetS-Z-WC in assessing correlations with future coronary heart disease (CHD) and Type 2 diabetes mellitus (T2DM) using Cox proportional hazard analysis of 13,094 participants of the Atherosclerosis Risk in Communities study and Jackson Heart Study.

Results: Loading factors, which represent the relative contribution of each component to the latent MetS factor, were lower for BMI than for WC in formulating the two respective scores (MetS-Z-BMI and MetS-Z-WC). Nevertheless, MetS-Z-BMI and MetS-Z-WC exhibited similar hazard ratios (HR) toward future disease. For each one standard-deviation-unit increase in MetS-Z-BMI, HR for CHD was 1.76 (95% confidence interval [CI]: 1.65, 1.88) and HR for T2DM was 3.39 (CI 3.16, 3.63) (both p < 0.0001). There were no meaningful differences between the MetS-Z-WC and MetS-Z-BMI scores in their associations with future CHD and T2DM.

Conclusions: A MetS severity Z-score utilizing BMI as its measure of adiposity operated similarly to a WC-based score in predicting future CHD and T2DM, suggesting overall similarity in MetS-based risk as estimated by both measures of adiposity. This indicates potential clinical usefulness of MetS-Z-BMI in assessing and following MetS-related risk over time.

Citing Articles

The association between inflammatory markers, walking speed, and metabolic syndrome in older Chinese adults.

Dai D, Zhao L, Li S, Xu Y, Du A Aging Clin Exp Res. 2025; 37(1):54.

PMID: 40011300 PMC: 11865104. DOI: 10.1007/s40520-025-02984-y.


Metabolic Syndrome Is Associated With Poor Prognosis in Patients With Breast Cancer Receiving Neoadjuvant Therapy.

Ma Y, Zhang J, Jiao D, Chen X, Liu Z Cancer Med. 2024; 13(24):e70484.

PMID: 39704402 PMC: 11660380. DOI: 10.1002/cam4.70484.


Exploratory analysis of the variable response to an intensive lifestyle change program for metabolic syndrome.

Maitland S, Brauer P, Mutch D, Royall D, Klein D, Tremblay A BMC Prim Care. 2024; 25(1):357.

PMID: 39354341 PMC: 11443702. DOI: 10.1186/s12875-024-02608-w.


Metabolic dysfunction and incidence of heart failure subtypes among Black individuals: The Jackson Heart Study.

Kaze A, Bertoni A, Fox E, Hall M, Mentz R, Echouffo-Tcheugui J Eur J Heart Fail. 2024; .

PMID: 39225160 PMC: 11873178. DOI: 10.1002/ejhf.3447.


Effects of Metabolic Syndrome on Pregnancy Outcomes in Women Without Polycystic Ovary Syndrome.

Li S, Ma S, Yao X, Liu P J Endocr Soc. 2024; 8(10):bvae143.

PMID: 39224458 PMC: 11368129. DOI: 10.1210/jendso/bvae143.


References
1.
DAgostino Sr R, Vasan R, Pencina M, Wolf P, Cobain M, Massaro J . General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008; 117(6):743-53. DOI: 10.1161/CIRCULATIONAHA.107.699579. View

2.
Fraser A, Longnecker M, Lawlor D . Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004. Gastroenterology. 2007; 133(6):1814-20. PMC: 2180388. DOI: 10.1053/j.gastro.2007.08.077. View

3.
Effoe V, Correa A, Chen H, Lacy M, Bertoni A . High-Sensitivity C-Reactive Protein Is Associated With Incident Type 2 Diabetes Among African Americans: The Jackson Heart Study. Diabetes Care. 2015; 38(9):1694-700. PMC: 4542275. DOI: 10.2337/dc15-0221. View

4.
Sumner A, Cowie C . Ethnic differences in the ability of triglyceride levels to identify insulin resistance. Atherosclerosis. 2007; 196(2):696-703. DOI: 10.1016/j.atherosclerosis.2006.12.018. View

5.
de Ferranti S, Mozaffarian D . The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem. 2008; 54(6):945-55. DOI: 10.1373/clinchem.2007.100156. View